Left Ventricular Mechano-Energetic Efficiency Identifies an Early Impairment of Myocardial Blood Flow in Arterial Hypertension.

coronary artery disease echocardiography efficiency hypertension positron emission tomography computed tomography

Journal

Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255

Informations de publication

Date de publication:
07 2023
Historique:
medline: 16 6 2023
pubmed: 12 5 2023
entrez: 12 5 2023
Statut: ppublish

Résumé

Arterial hypertension causes cardiac functional and structural alterations. In hypertensive patients without flow-limiting epicardial coronary artery disease, we investigated possible relationships between positron emission tomography/computed tomography-derived myocardial blood flow (MBF) and echocardiographic parameters of left ventricular (LV) performance, including mechano-energetic efficiency indexed for myocardial mass (MEEi). Seventy-eight hypertensive patients without flow-limiting epicardial coronary artery disease underwent echocardiography, including MEEi computation, and cardiac positron emission tomography/computed tomography with assessment of MBF/mass ratio at rest and after stress and myocardial flow reserve. The lowest MEEi tertile (MEEi<0.031 mL/s/g) was compared to the merged second and third tertiles (MEEi≥0.031). Patients in the lowest MEEi tertile were older, had higher systolic blood pressure and body mass index. They also had higher prevalence of LV hypertrophy, whereas lower resting and stress MBF/mass ratio. MEEi was significantly correlated with both resting (r=0.51; In hypertensive patients without flow-limiting epicardial coronary artery disease, low values of MEEi could detect an early LV dysfunction involving an impairment of both resting and hyperemic MBF/mass ratios. MEEi has the advantage of simpler detection, cheaper costs than positron emission tomography/computed tomography, and a lack of radiation exposure. URL: https://www. gov; Unique identifier: NCT02211365.

Sections du résumé

BACKGROUND
Arterial hypertension causes cardiac functional and structural alterations. In hypertensive patients without flow-limiting epicardial coronary artery disease, we investigated possible relationships between positron emission tomography/computed tomography-derived myocardial blood flow (MBF) and echocardiographic parameters of left ventricular (LV) performance, including mechano-energetic efficiency indexed for myocardial mass (MEEi).
METHODS
Seventy-eight hypertensive patients without flow-limiting epicardial coronary artery disease underwent echocardiography, including MEEi computation, and cardiac positron emission tomography/computed tomography with assessment of MBF/mass ratio at rest and after stress and myocardial flow reserve. The lowest MEEi tertile (MEEi<0.031 mL/s/g) was compared to the merged second and third tertiles (MEEi≥0.031).
RESULTS
Patients in the lowest MEEi tertile were older, had higher systolic blood pressure and body mass index. They also had higher prevalence of LV hypertrophy, whereas lower resting and stress MBF/mass ratio. MEEi was significantly correlated with both resting (r=0.51;
CONCLUSIONS
In hypertensive patients without flow-limiting epicardial coronary artery disease, low values of MEEi could detect an early LV dysfunction involving an impairment of both resting and hyperemic MBF/mass ratios. MEEi has the advantage of simpler detection, cheaper costs than positron emission tomography/computed tomography, and a lack of radiation exposure.
REGISTRATION
URL: https://www.
CLINICALTRIALS
gov; Unique identifier: NCT02211365.

Identifiants

pubmed: 37170833
doi: 10.1161/HYPERTENSIONAHA.123.21071
doi:

Banques de données

ClinicalTrials.gov
['NCT02211365']

Types de publication

Clinical Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1534-1543

Auteurs

Maria Lembo (M)

Department of Advanced Biomedical Sciences, Federico II University of Naples (M.L., W.A., M.V.M., C.M., G.E., R.A., E.Z., C.N., V.G., T.M., C.M., G.d.S., R.I., A.C., B.T.).

Wanda Acampa (W)

Department of Advanced Biomedical Sciences, Federico II University of Naples (M.L., W.A., M.V.M., C.M., G.E., R.A., E.Z., C.N., V.G., T.M., C.M., G.d.S., R.I., A.C., B.T.).

Maria Assunta Elena Rao (MAE)

Federico II University Hospital (M.A.E.R.).

Maria Virginia Manzi (MV)

Department of Advanced Biomedical Sciences, Federico II University of Naples (M.L., W.A., M.V.M., C.M., G.E., R.A., E.Z., C.N., V.G., T.M., C.M., G.d.S., R.I., A.C., B.T.).

Carmine Morisco (C)

Department of Advanced Biomedical Sciences, Federico II University of Naples (M.L., W.A., M.V.M., C.M., G.E., R.A., E.Z., C.N., V.G., T.M., C.M., G.d.S., R.I., A.C., B.T.).

Giovanni Esposito (G)

Department of Advanced Biomedical Sciences, Federico II University of Naples (M.L., W.A., M.V.M., C.M., G.E., R.A., E.Z., C.N., V.G., T.M., C.M., G.d.S., R.I., A.C., B.T.).

Roberta Assante (R)

Department of Advanced Biomedical Sciences, Federico II University of Naples (M.L., W.A., M.V.M., C.M., G.E., R.A., E.Z., C.N., V.G., T.M., C.M., G.d.S., R.I., A.C., B.T.).

Emilia Zampella (E)

Department of Advanced Biomedical Sciences, Federico II University of Naples (M.L., W.A., M.V.M., C.M., G.E., R.A., E.Z., C.N., V.G., T.M., C.M., G.d.S., R.I., A.C., B.T.).

Carmela Nappi (C)

Department of Advanced Biomedical Sciences, Federico II University of Naples (M.L., W.A., M.V.M., C.M., G.E., R.A., E.Z., C.N., V.G., T.M., C.M., G.d.S., R.I., A.C., B.T.).

Valeria Gaudieri (V)

Department of Advanced Biomedical Sciences, Federico II University of Naples (M.L., W.A., M.V.M., C.M., G.E., R.A., E.Z., C.N., V.G., T.M., C.M., G.d.S., R.I., A.C., B.T.).

Teresa Mannarino (T)

Department of Advanced Biomedical Sciences, Federico II University of Naples (M.L., W.A., M.V.M., C.M., G.E., R.A., E.Z., C.N., V.G., T.M., C.M., G.d.S., R.I., A.C., B.T.).

Costantino Mancusi (C)

Department of Advanced Biomedical Sciences, Federico II University of Naples (M.L., W.A., M.V.M., C.M., G.E., R.A., E.Z., C.N., V.G., T.M., C.M., G.d.S., R.I., A.C., B.T.).

Giovanni de Simone (G)

Department of Advanced Biomedical Sciences, Federico II University of Naples (M.L., W.A., M.V.M., C.M., G.E., R.A., E.Z., C.N., V.G., T.M., C.M., G.d.S., R.I., A.C., B.T.).

Raffaele Izzo (R)

Department of Advanced Biomedical Sciences, Federico II University of Naples (M.L., W.A., M.V.M., C.M., G.E., R.A., E.Z., C.N., V.G., T.M., C.M., G.d.S., R.I., A.C., B.T.).

Alberto Cuocolo (A)

Department of Advanced Biomedical Sciences, Federico II University of Naples (M.L., W.A., M.V.M., C.M., G.E., R.A., E.Z., C.N., V.G., T.M., C.M., G.d.S., R.I., A.C., B.T.).

Bruno Trimarco (B)

Department of Advanced Biomedical Sciences, Federico II University of Naples (M.L., W.A., M.V.M., C.M., G.E., R.A., E.Z., C.N., V.G., T.M., C.M., G.d.S., R.I., A.C., B.T.).
International Translational Research and Medical Education (ITME) Consortium (B.T.), Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH